Northrop Grumman shares traded near $551 in late October 2026, marking a gain of roughly 8% over the prior 30 days after the stock sat near $510 a month earlier. The move accelerated following the company's third-quarter earnings release on October 20, when shares rallied on a profit beat, raised guidance, and a record order backlog.
The advance fits within a broader recovery narrative for defense contractors. After a period of pressure earlier in the year tied to rising interest rates, inflation concerns, and questions around contracting reform, investors have refocused on the durability of Northrop Grumman's demand. A record backlog and strong bookings provided renewed confidence in multi-year revenue visibility, even as the stock continues to trade below levels seen earlier in the cycle. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Northrop Grumman is one of the world's largest aerospace and defense technology companies, serving the U.S. government and allied nations across four operating segments: Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems. The company is the prime contractor for the U.S. Air Force's B-21 Raider stealth bomber and the Sentinel intercontinental ballistic missile program, and it holds leading positions in national security space, missile defense, autonomous systems, and advanced microelectronics.
With nearly 100,000 employees and more than 30 million square feet of manufacturing space, Northrop Grumman competes alongside peers such as Lockheed Martin (LMT) for large, multi-decade defense programs. Its competitive strengths include deep franchise positions in strategic deterrence, space superiority, and munitions, as well as a track record of disciplined program execution that supports recurring revenue and cash flow. Investors follow the stock closely because its backlog and government-funded programs provide relatively predictable, long-horizon growth tied to national security priorities.
The primary catalyst over the last 30 days was the company's third-quarter 2026 report. Sales rose 7% to $11.1 billion, while diluted EPS of $7.89 beat expectations by roughly $0.70. Segment operating margin reached 12.1%, and adjusted free cash flow climbed more than 40% year over year to $1.8 billion, aided by working capital improvements and proceeds from a B-21 test asset sale.
Demand was the standout theme. Net awards totaled about $16.4 billion, driving a record $110 billion backlog. Key awards included roughly $4.6 billion on restricted programs, an additional $2 billion on Sentinel, and three E-2D aircraft. On the strength of this performance, management raised its 2026 EPS outlook and segment operating income guidance, while reaffirming full-year sales of $43.75 billion to $44.25 billion.
Beyond earnings, the company continued to advance its strategic programs. Northrop Grumman completed the first full vertical assembly of an inert Sentinel missile and gained U.S. Air Force approval to proceed toward a first flight in 2027. In space, it launched and deployed its first 21 satellites for the Tranche 1 transport layer. The company also introduced new counter-UAS offerings and signed multi-year framework agreements with Lockheed Martin (LMT) valued at over $3 billion to accelerate production of PAC-3 MSE solid rocket motors and THAAD components.
Looking ahead, investors will monitor how Northrop Grumman converts its record backlog into sales and margin expansion. For 2026, management raised its EPS guidance to $29.35 to $29.75 and reaffirmed sales guidance, signaling confidence in near-term execution. The initial 2027 outlook calls for sales growth of 5% to 7%, modest margin expansion, and adjusted free cash flow of $3.3 billion to $3.7 billion, with higher capital expenditures tied to B-21 production acceleration.
Key factors to watch include the timing of U.S. defense appropriations, given that the company is operating under a continuing resolution; progress on the B-21 ramp and Sentinel milestones; the pace of international sales growth; and demand for munitions and missile defense amid elevated global security spending. Execution risk on large development programs and capital investment pressures remain among the variables that could influence the stock's trajectory. The information above is provided for context and does not constitute investment advice or a prediction of future performance. From what I see, the backlog conversion pace will be especially telling in the quarters ahead.
In my research process, I often turn to Tickeron’s AI Trading Bots to see how automated strategies are performing around names like this. The platform features a range of bots with varying timeframes and approaches, which provides a helpful way to cross-reference systematic signals against my own fundamental views without replacing core analysis.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
NOC moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend. In 38 of 51 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 75%.
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on NOC as a result. In 40 of 72 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 56%.
The Moving Average Convergence Divergence (MACD) for NOC just turned positive on October 14, 2026. Looking at past instances where NOC's MACD turned positive, the stock continued to rise in 22 of 45 cases over the following month. The odds of a continued upward trend are 49%.
Following a +3.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where NOC advanced for three days, in 196 of 323 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.
The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NOC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 49%.
NOC broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for NOC entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 36 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating steady price growth. NOC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 54 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is 65 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.380) is normal, around the industry mean (4.788). P/E Ratio (17.495) is within average values for comparable stocks, (16.638). Projected Growth (PEG Ratio) (3.350) is also within normal values, averaging (2.564). Dividend Yield (0.018) settles around the average of (0.060) among similar stocks. P/S Ratio (1.766) is also within normal values, averaging (18.330).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of innovative systems, products and solutions in aerospace, electronics and information systems
Industry AerospaceDefense